Track record · closed signal

Opera Limited (OPRA) — closed signal from March 3, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on June 1, 2026.

Predicted vs. what happened

OPRA price · publication thesis → realized outcomesplit-adjusted
$15.46 Published $20.10 Target $19.31 Window close $19.38 Peak
$14.20 – $15.20Entry zone — fair-value band
$15.46Published — price the day we called it
$20.10Target — the price the thesis aimed for
$19.38Peak — highest point inside the window, not a realized return
$19.31Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price
$19.38
peak on June 1, 2026 — not a realized return
Peak gain
+25.4%
peak, from the publication price
Window close
$19.31
end-of-window price, context only
Days to target
Window
March 3, 2026 – June 1, 2026

The thesis — published March 3, 2026

Predicted growth
+30%
over the measurement window
Target price
$20.10
the price the thesis aimed for
Entry zone
$14.20 – $15.20
the fair-value band we waited for
Price at publication
$15.46
published March 3, 2026
Confidence
71%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

- Checklist: summarize catalysts, explain why they matter, state entry advice OPRA recently reported better-than-expected sales, management gave upbeat guidance to 2026, and the company approved a $300M buyback. Analysts raised targets, which can attract interest. The stock has already moved up and can swing widely, so waiting for a pullback into the entry range helps avoid buying at the top.

Primary drivers

  • Upbeat 2026 guidance could change investor interest
  • $300M buyback helps create steady demand for shares
  • Higher analyst targets can draw more investor attention
  • Sales beat adds credibility but stock can be volatile so be disciplined

How it played out

OPRA: rose 25.4%, but missed the $20.10 target

Lyra published OPRA at $15.46 on March 3, with a short-term thesis for 30% growth. The thesis pointed to better-than-expected sales, upbeat 2026 guidance, a $300M buyback, higher analyst targets, and volatility that made the $14.20 to $15.20 entry zone relevant.

Inside the window, OPRA rose to a peak of $19.38 on June 1. That was a 25.4% gain, but it stayed below the $20.10 target and never reached it. The stock ended at $19.31. The thesis mostly played out on price direction, but it missed the published target.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.